Cargando…
Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
Lassa virus (LASV) is the causative agent of Lassa Fever and is responsible for several hundred thousand infections and thousands of deaths annually in West Africa. LASV and the non-pathogenic Mopeia virus (MOPV) are both rodent-borne African arenaviruses. A live attenuated reassortant of MOPV and L...
Autores principales: | Zapata, Juan Carlos, Carrion, Ricardo, Patterson, Jean L., Crasta, Oswald, Zhang, Yan, Mani, Sachin, Jett, Marti, Poonia, Bhawna, Djavani, Mahmoud, White, David M., Lukashevich, Igor S., Salvato, Maria S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772037/ https://www.ncbi.nlm.nih.gov/pubmed/24069471 http://dx.doi.org/10.1371/journal.pntd.0002406 |
Ejemplares similares
-
Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1(-/-) Mice
por: Johnson, Dylan M., et al.
Publicado: (2019) -
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
por: Zapata, Juan C, et al.
Publicado: (2013) -
Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses
por: Baillet, Nicolas, et al.
Publicado: (2019) -
Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation
por: Johnson, Dylan M., et al.
Publicado: (2021) -
Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)